A carregar...

Secondary mutations as mediators of resistance to targeted therapy in leukemia

The advent of small molecule-based targeted therapy has improved the treatment of both acute and chronic leukemias. Resistance to small molecule inhibitors has emerged as a common theme. The most frequent mode of acquired resistance is the acquisition of point mutations in the kinase domain. FLT3 in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Daver, Naval, Cortes, Jorge, Ravandi, Farhad, Patel, Keyur P., Burger, Jan A., Konopleva, Marina, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4440880/
https://ncbi.nlm.nih.gov/pubmed/25795921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-605808
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!